Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

Clinical trial NCT00211484 · COMPLETED

Trial details

NCT number: NCT00211484
Sponsor: Manhattan Eye, Ear & Throat Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Age-Related Macular Degenerations.Subfoveal Neovascularization.

Start date: 2003-05-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.